Compare Humana Inc (HUM) vs KKR & Co Inc (KKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs KKR & Co Inc — how do they compare? Humana Inc trades at $436.33 (market cap $46.49B), while KKR & Co Inc trades at $91.6 (market cap $80.39B). The key difference: KKR & Co Inc is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.91%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and KKR & Co Inc for 67 Days on average.
| HUM | KKR | |
|---|---|---|
Market Cap | $46.49B | $80.39B |
Volume | 2,567,704 | 6,517,705 |
Sector | Health | Financials |
52-Week High | $409.85 | $142.75 |
52-Week Low | $163.67 | $83.88 |
Typical Hold Time | 53 Days | 67 Days |
Enterprise Value | $53.84B | $2.95B |
Dividend Yield | 0.91% | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
KKR trades at $89.67, down 1.1% on the day, with strong analyst support (89% buy ratings) and a $123.30 consensus price target suggesting 38% upside. Recent earnings show mixed results with Q4 2025 missing expectations but Q1 and Q2 2026 beating estimates. The company maintains solid profitability with 14.97% net income margin and 10.99% ROE, while recent business developments include strategic joint ventures and asset sales across global markets.
KKR presents a compelling investment case with strong institutional backing and consistent earnings growth, though technical indicators show bearish momentum. Key risks include market volatility and execution challenges in global investments. The significant discount to analyst targets and recent strategic moves position the stock for potential recovery despite current technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About KKR & Co Inc
KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →
